Extending the reach of Thomson Pharma

This optional add-on content integrates information on clinical trials into Thomson Pharma, and exclusive Target reports from Entelos Inc. You can choose to subscribe to them in addition to your standard Thomson Pharma subscription.

Fully integrated into the core solution, they strengthen the position of Thomson Pharma as the must-have information solution for professionals working at all stages of drug development.

Clinical Trials
Subscribe to additional high-quality curated clinical trial protocol and outcome records, chosen by therapy area.

Entelos Target reports
Thomson Reuters is able to supply exclusive target reports from Entelos Inc, the leader in predictive biosimulation, including specially-compiled custom reports for your own lead compounds.